NCT03052972View on ClinicalTrials.gov

Flortaucipir 18F PET Imaging in BIOCARD Study

PHASE1TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 23, 2017

Primary Completion Date

August 14, 2018

Study Completion Date

August 17, 2018

Conditions
Cognitive Decline
Interventions
DRUG

Flortaucipir F18

370 megabecquerel (MBq)(10 millicurie \[mCi\]) single dose

PROCEDURE

Brain PET scan

positron emission tomography (PET) scan of the brain

Trial Locations (1)

21205

Johns Hopkins Hospital, Baltimore

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY